Anna Gilmore
Cited by
Cited by
Exposing and addressing tobacco industry conduct in low-income and middle-income countries
AB Gilmore, G Fooks, J Drope, SA Bialous, RR Jackson
The Lancet 385 (9972), 1029-1043, 2015
The limits of corporate social responsibility: techniques of neutralization, stakeholder management and political CSR
G Fooks, A Gilmore, J Collin, C Holden, K Lee
Journal of business ethics 112, 283-299, 2013
Globalization and infectious diseases: a review of the linkages
L Saker, K Lee, B Cannito, A Gilmore, DH Campbell-Lendrum
World Health Organization, 2004
How does the alcohol industry attempt to influence marketing regulations? A systematic review
E Savell, G Fooks, AB Gilmore
Addiction 111 (1), 18-32, 2016
How does the tobacco industry attempt to influence marketing regulations? A systematic review
E Savell, AB Gilmore, G Fooks
PloS one 9 (2), e87389, 2014
Determinants of and inequalities in self-perceived health in Ukraine
ABC Gilmore, M McKee, R Rose
Social science & medicine 55 (12), 2177-2188, 2002
Prevalence of smoking in 8 countries of the former Soviet Union: results from the living conditions, lifestyles and health study
A Gilmore, J Pomerleau, M McKee, R Rose, CW Haerpfer, D Rotman, ...
American journal of public health 94 (12), 2177-2187, 2004
Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction
M Sims, R Maxwell, L Bauld, A Gilmore
Bmj 340, 2010
The policy dystopia model: an interpretive analysis of tobacco industry political activity
S Ulucanlar, GJ Fooks, AB Gilmore
PLoS medicine 13 (9), e1002125, 2016
Defining and conceptualising the commercial determinants of health
AB Gilmore, A Fabbri, F Baum, A Bertscher, K Bondy, HJ Chang, ...
The Lancet 401 (10383), 1194-1213, 2023
What is known about tobacco industry efforts to influence tobacco tax? A systematic review of empirical studies
KE Smith, E Savell, AB Gilmore
Tobacco control 22 (2), e1-e1, 2013
Public health, corporations and the new responsibility deal: promoting partnerships with vectors of disease?
AB Gilmore, E Savell, J Collin
Journal of Public Health 33 (1), 2-4, 2011
Tobacco industry influence on science and scientists in Germany
T Grüning, AB Gilmore, M McKee
American Journal of Public Health 96 (1), 20-32, 2006
Corporate social responsibility and access to policy élites: an analysis of tobacco industry documents
GJ Fooks, AB Gilmore, KE Smith, J Collin, C Holden, K Lee
PLoS medicine 8 (8), e1001076, 2011
Trends in the prevalence of smoking in Russia during the transition to a market economy
F Perlman, M Bobak, A Gilmore, M McKee
Tobacco control 16 (5), 299-305, 2007
Understanding tobacco industry pricing strategy and whether it undermines tobacco tax policy: the example of the UK cigarette market
AB Gilmore, B Tavakoly, G Taylor, H Reed
Addiction 108 (7), 1317-1326, 2013
E-cigarettes and equity: a systematic review of differences in awareness and use between sociodemographic groups
G Hartwell, S Thomas, M Egan, A Gilmore, M Petticrew
Tobacco control 26 (e2), e85-e91, 2017
Moving East: how the transnational tobacco industry gained entry to the emerging markets of the former Soviet Union—part I: establishing cigarette imports
AB Gilmore, M McKee
Tobacco control 13 (2), 143-150, 2004
Changes in smoking prevalence in Russia, 1996–2004
M Bobak, A Gilmore, M McKee, R Rose, M Marmot
Tobacco control 15 (2), 131-135, 2006
“Working the system”—British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents
KE Smith, G Fooks, J Collin, H Weishaar, S Mandal, AB Gilmore
PLoS Medicine 7 (1), e1000202, 2010
The system can't perform the operation now. Try again later.
Articles 1–20